| Product Code: ETC6955905 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Circulating Tumor DNA (ctDNA) Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Circulating Tumor DNA (ctDNA) Market - Industry Life Cycle |
3.4 Denmark Circulating Tumor DNA (ctDNA) Market - Porter's Five Forces |
3.5 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.7 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Denmark Circulating Tumor DNA (ctDNA) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Denmark |
4.2.2 Growing adoption of liquid biopsy for cancer diagnosis and monitoring |
4.2.3 Technological advancements in the field of genomics and molecular diagnostics |
4.3 Market Restraints |
4.3.1 High cost associated with ctdna testing |
4.3.2 Limited reimbursement policies for ctdna testing in Denmark |
4.3.3 Lack of awareness among healthcare professionals and patients about the benefits of ctdna testing |
5 Denmark Circulating Tumor DNA (ctDNA) Market Trends |
6 Denmark Circulating Tumor DNA (ctDNA) Market, By Types |
6.1 Denmark Circulating Tumor DNA (ctDNA) Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Routine Screening, 2021- 2031F |
6.1.4 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Patient Work Up, 2021- 2031F |
6.1.5 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Early-Stage Disease, 2021- 2031F |
6.1.6 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Late Stage/Metastatic Disease, 2021- 2031F |
6.2 Denmark Circulating Tumor DNA (ctDNA) Market, By Sample |
6.2.1 Overview and Analysis |
6.2.2 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Blood, 2021- 2031F |
6.2.3 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Urine, 2021- 2031F |
6.2.4 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Denmark Circulating Tumor DNA (ctDNA) Market, By Method |
6.3.1 Overview and Analysis |
6.3.2 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Sample Preparation, 2021- 2031F |
6.3.3 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Ultra-Low Passage Whole Genome Sequencing,, 2021- 2031F |
6.3.4 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By ctDNA Quantification, 2021- 2031F |
6.3.5 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Copy Number Analysis, 2021- 2031F |
6.3.6 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Statistical Analysis, 2021- 2031F |
6.4 Denmark Circulating Tumor DNA (ctDNA) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.4 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Academia, 2021- 2031F |
6.4.5 Denmark Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Centers, 2021- 2031F |
7 Denmark Circulating Tumor DNA (ctDNA) Market Import-Export Trade Statistics |
7.1 Denmark Circulating Tumor DNA (ctDNA) Market Export to Major Countries |
7.2 Denmark Circulating Tumor DNA (ctDNA) Market Imports from Major Countries |
8 Denmark Circulating Tumor DNA (ctDNA) Market Key Performance Indicators |
8.1 Adoption rate of liquid biopsy technologies in Denmark |
8.2 Number of research studies and clinical trials utilizing ctdna testing |
8.3 Rate of integration of ctdna testing in clinical practice |
9 Denmark Circulating Tumor DNA (ctDNA) Market - Opportunity Assessment |
9.1 Denmark Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Denmark Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.3 Denmark Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Method, 2021 & 2031F |
9.4 Denmark Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Denmark Circulating Tumor DNA (ctDNA) Market - Competitive Landscape |
10.1 Denmark Circulating Tumor DNA (ctDNA) Market Revenue Share, By Companies, 2024 |
10.2 Denmark Circulating Tumor DNA (ctDNA) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here